Viveve Medical Inc Revenue Growth Rates (VIVE), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Viveve Medical Inc   (NASDAQ: VIVE)
 

VIVE's Revenue Growth by Quarter and Year

Viveve Medical Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VIVE Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
4th Quarter December -
3rd Quarter September 1.68
2nd Quarter June 1.80
1st Quarter March 1.64
FY 5.12

VIVEs Annual Revenue
Viveve Medical Inc 's Revenue in the fiscal year 2021 $ 6.43 millions
Viveve Medical Inc 's Revenue in the fiscal year 2020 $ 5.48 millions
Viveve Medical Inc 's Revenue in the fiscal year 2019 $ 6.57 millions
Viveve Medical Inc 's Revenue in the fiscal year 2018 $ 18.52 millions
Viveve Medical Inc 's Revenue in the fiscal year 2017 $ 15.29 millions




VIVE Revenue third quarter 2022 Y/Y Growth Comment
Viveve Medical Inc reported Revenue growth of 3.95% year on year in the third quarter 2022, to $ 1.68 millions, this is lower than Viveve Medical Inc 's recent average Revenue surge of 286.73%.

Looking into third quarter 2022 results within Medical Equipment & Supplies industry 125 other companies have achieved higher Revenue growth. While Viveve Medical Inc ' s Revenue increase of 3.95% ranks overall at the positon no. 2819 in the third quarter 2022.


VIVE Revenue ( Y/Y Growth %) 2022
 2021 2020 2019
4th Quarter December - -12.31 % 34.48 % -67.56 %
3rd Quarter September 3.95 % 6.58 % 44.76 % -78.22 %
2nd Quarter June 9.09 % 135.71 % -33.33 % -81.01 %
1st Quarter March 13.1 % 11.54 % -56.81 % -18.65 %
FY   - 17.55 % -16.62 % -

Financial Statements
Viveve Medical Inc 's third quarter 2022 Revenue $ 1.68 millions VIVE's Income Statement
Viveve Medical Inc 's third quarter 2021 Revenue $ 1.62 millions Quarterly VIVE's Income Statement


VIVE Revenue (Quarter on Quarter Growth %)

 2022
 2021 2020 2019
4th Quarter December - 5.56 % 28.29 % 38.1 %
3rd Quarter September -6.44 % -1.82 % 117.14 % 0 %
2nd Quarter June 9.76 % 13.79 % -46.15 % -65.12 %
1st Quarter March -4.09 % -25.64 % -10.34 % -32.66 %
FY (Year on Year)   - 17.55 % -16.62 % -


Back to VIVE Growth rate Comparisons >> Back to VIVE Growth rate Comparisons >>


Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #126
Healthcare Sector #390
Overall #2819

Revenue Y/Y Growth Statistics
High Average Low
3299.3 % 286.73 % -97.83 %
(Sep 30 2015)   (Jun 30 2019)
Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #126
Healthcare Sector #390
Overall #2819
Revenue Y/Y Growth Statistics
High Average Low
3299.3 % 286.73 % -97.83 %
(Sep 30 2015)   (Jun 30 2019)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Viveve Medical Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
700 % 34.31 % -76.47 %
(Sep 30 2015)  


VIVE's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2022 Viveve Medical Inc disclosed decline in Revenue from the second quarter by -6.44% to $ 1.68 millions, from $ 1.80 millions achived in the previous reporting period.

But that's not important problem, as Viveve Medical Inc 's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 159 other companies have achieved higher Revenue quarter on quarter growth. While Viveve Medical Inc 's Revenue growth quarter on quarter, overall rank is 3365.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #160
Healthcare Sector #513
Overall #3365
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #160
Healthcare Sector #513
Overall #3365
Revenue Q/Q Growth Statistics
High Average Low
700 % 34.31 % -76.47 %
(Sep 30 2015)  


VIVE's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2022 Viveve Medical Inc disclosed decline in Revenue from the second quarter by -6.44% to $ 1.68 millions, from $ 1.80 millions achived in the previous reporting period.

But that's not important problem, as Viveve Medical Inc 's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 159 other companies have achieved higher Revenue quarter on quarter growth. While Viveve Medical Inc 's Revenue growth quarter on quarter, overall rank is 3365.


Viveve Medical Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2022)		 12 Months Ending
(Jun 30 2022)		 12 Months Ending
(Mar 31 2022)		 12 Months Ending
(Dec 31 2021)		 12 Months Ending
(Sep 30 2021)
Cumulative Revenue 12 Months Ending $ 6.83 $ 6.76 $ 6.62 $ 6.43 $ 6.67
Y / Y Revenue Growth (TTM) 2.38 % 2.78 % 17.64 % 17.28 % 33.79 %
Year on Year Revenue Growth Overall Ranking # 1045 # 2036 # 1560 # 1375 # 878
Seqeuential Revenue Change (TTM) 1.01 % 2.13 % 2.97 % -3.61 % 1.4 %
Seq. Revenue Growth (TTM) Overall Ranking # 2694 # 1664 # 1919 # 2641 # 1978


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2022 period, Viveve Medical Inc 's cumulative twelve months Revenue were $ 7 millions, company would post below average annual Revenue growth of 1.4% year on year, if the fiscal year would end at Sep 30 2022.
A slow-down in the Viveve Medical Inc 's Revenue growth from the 1.8% growth in Jun 30 2022.

In the Healthcare sector 175 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1045, from total ranking in previous quarter at 2036.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 105
Healthcare Sector # 176
Overall # 1045

Revenue TTM Y/Y Growth Statistics
High Average Low
5543.24 %
 317.47 %
-207.71 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 105
Sector # 358
S&P 500 # 2694
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2022 period, Viveve Medical Inc 's cumulative twelve months Revenue were $ 7 millions, company would post below average annual Revenue growth of -207.71% year on year, if the fiscal year would end at Sep 30 2022.
A slow-down in the Viveve Medical Inc 's Revenue growth from the 1.8% growth in Jun 30 2022.

In the Healthcare sector 175 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1045, from total ranking in previous quarter at 2036.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 105
Healthcare Sector # 176
Overall # 1045

Revenue TTM Y/Y Growth Statistics
High Average Low
5543.24 %
317.47 %
-207.71 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 105
Sector # 358
S&P 500 # 2694




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
VIVE's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decline for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2022
Fuse Medical Inc 6.73%$ 6.729 millions
Cryoport inc 6.65%$ 6.652 millions
Electromed Inc 6.57%$ 6.569 millions
Acorda Therapeutics Inc 6.53%$ 6.533 millions
Isoplexis Corporation6.32%$ 6.316 millions
Corcept Therapeutics Inc5.82%$ 5.822 millions
The Pennant Group Inc 5.74%$ 5.744 millions
Universal Health Services Inc 5.70%$ 5.704 millions
Outset Medical Inc 5.48%$ 5.483 millions
Fate Therapeutics Inc 5.31%$ 5.315 millions
Radnet Inc 5.22%$ 5.216 millions
Milestone Scientific Inc 5.10%$ 5.097 millions
Iqvia Holdings Inc 5.04%$ 5.043 millions
Caredx Inc 4.99%$ 4.987 millions
Xtant Medical Holdings Inc 4.97%$ 4.972 millions
Maxcyte inc 4.97%$ 4.968 millions
Sonida Senior Living Inc 4.94%$ 4.943 millions
Bruker Corporation4.93%$ 4.927 millions
Prestige Consumer Healthcare Inc 4.72%$ 4.724 millions
Ironwood Pharmaceuticals inc 4.71%$ 4.713 millions
Bio techne Corp4.61%$ 4.608 millions
10x Genomics Inc 4.31%$ 4.308 millions
Viveve Medical Inc 4.21%$ 4.208 millions
Atrion Corporation4.14%$ 4.144 millions
Icon Plc4.08%$ 4.076 millions
Rigel Pharmaceuticals Inc4.02%$ 4.025 millions
Idexx Laboratories Inc3.85%$ 3.855 millions
Athenex Inc 3.82%$ 3.818 millions
Mettler toledo International Inc 3.56%$ 3.561 millions
Nabriva Therapeutics Plc3.28%$ 3.284 millions


About Viveve Medical Inc Revenue Growth Rates (VIVE), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Viveve Medical Inc (CIK 879682).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001437749-22-026899
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Viveve Medical Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.